Skip to main content
. 2022 Apr 23;22:118. doi: 10.1186/s12871-022-01641-5

Table 7.

Comparison of adverse reactions [n (%)]

Groups n Nausea and vomiting Hypoxemia Respiratory depression Emergence agitation Dizziness Total incidence
Remimazolam group 30 1 (3.33) 0 (0.00) 0 (0.00) 1 (3.33) 1 (3.33) 3 (10.00)
Propofol group 29 3 (10.34) 1 (3.45) 1 (3.45) 3 (10.34) 2 (6.90) 10 (34.48)
x2 5.145
P 0.023